Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 11—November 2006
Perspective

Prophylaxis and Treatment of Pregnant Women for Emerging Infections and Bioterrorism Emergencies

Joanne Cono*Comments to Author , Janet D. Cragan*, Denise J. Jamieson*, and Sonja A. Rasmussen*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 2

US Food and Drug Administration pregnancy classifications of bioterrorism medical countermeasures

Medication Category Potential use
Amoxicillin B Anthrax
Ampicillin B Anthrax
Botulinum antitoxin Unlicensed/C* Botulism
Cidofovir C Vaccinia, monkeypox, smallpox
Ciprofloxacin C Anthrax, plague, tularemia
Doxycycline D Anthrax, plague, tularemia
Gentamicin D Plague, tularemia
Penicillin B Anthrax
Smallpox vaccine Unlicensed/C* Smallpox, monkeypox
Vaccinia immune globulin C Vaccinia

*Multiple products/preparations.

*Multiple products/preparations.

Main Article

Page created: October 14, 2011
Page updated: October 14, 2011
Page reviewed: October 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external